NCT06350305Not yet recruiting
Screening for High-risk Chronic Obstructive Pulmonary Disease
Screening Study at High-risk Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 11 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is a multicenter cross-sectional study design aimed at screening risk factors for the combination of disease and syndrome in high-risk individuals with chronic obstructive pulmonary disease (COPD).
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 3600 (estimated)
- First submitted
- 1 Apr 2024
- Start date
- 1 May 2024
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- Henan University of Traditional Chinese Medicine
- Diseases
- COPD
- NCT number
- NCT06350305
What you commit to
- Study type: Observational
- Planned participants: 3600
- From 1 May 2024 to the primary completion date, 30 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who are delirious, have impaired consciousness, dementia, various psychiatric disorders, etc., and cannot be accurately informed of their basic physical condition.
Other
- Patients who, in the opinion of the investigator, are not suitable for participation in this study.
Who the study is looking for
- According to the Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (Revised in 2021), a multi-stage cluster random sampling method was used to select individuals from representative administrative villages with a history of chronic cough or sputum production, breathing difficulties, recurrent lower respiratory tract infections, and/or exposure to potential risk factors for chronic obstructive pulmonary disease.
- The investigators agreed to participate in this clinical study by voluntarily signing an informed consent form.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Henan University of Chinese Medicine Coordinator of this site? Confirm its status | Zhengzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.